BTIG maintained a Buy rating on Denali Therapeutics on July 16, 2025.
1 report, 1 independent
Updated Jul 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
BTIG maintained a Buy rating on Denali Therapeutics on July 16, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Denali Therapeutics (United States)
company in South San Francisco, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- Insider MonkeyBTIG Reiterates a Buy Rating on Denali Therapeutics (DNLI) With a $32 Price Target Denali Therapeutics, Inc. (NASDAQ:DNLI) is one of the best oversold NASDAQ stocks to buy now. In a report released o